Your browser doesn't support javascript.
loading
Effect of semaglutide 2.4 mg once weekly on 10-year type 2 diabetes risk in adults with overweight or obesity.
Wilkinson, Lua; Holst-Hansen, Thomas; Laursen, Peter N; Rinnov, Anders R; Batterham, Rachel L; Garvey, W Timothy.
Affiliation
  • Wilkinson L; Medical Affairs, Novo Nordisk Inc., Plainsboro, New Jersey, USA.
  • Holst-Hansen T; Medical Affairs, Novo Nordisk A/S, Søborg, Denmark.
  • Laursen PN; Medical Affairs, Novo Nordisk A/S, Søborg, Denmark.
  • Rinnov AR; Medical Affairs, Novo Nordisk A/S, Søborg, Denmark.
  • Batterham RL; University College London Centre for Obesity Research, Division of Medicine, University College London, London, UK.
  • Garvey WT; National Institute of Health Research, University College London Hospital Biomedical Research Centre, London, UK.
Obesity (Silver Spring) ; 31(9): 2249-2259, 2023 09.
Article in En | MEDLINE | ID: mdl-37605636
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Diabetes Mellitus, Type 2 Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Limits: Adult / Humans Language: En Journal: Obesity (Silver Spring) Journal subject: CIENCIAS DA NUTRICAO / FISIOLOGIA / METABOLISMO Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Diabetes Mellitus, Type 2 Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Limits: Adult / Humans Language: En Journal: Obesity (Silver Spring) Journal subject: CIENCIAS DA NUTRICAO / FISIOLOGIA / METABOLISMO Year: 2023 Document type: Article Affiliation country: Country of publication: